Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

5th Mar 2014 07:00

RNS Number : 5311B
Reed Elsevier PLC
04 March 2014
 



 

 

ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV

 

4 March 2014

 

 

Director/PDMR Shareholdings

 

Reed Elsevier announces that it today received notification of the following transactions in the securities of Reed Elsevier by Erik Engstrom, Director, and Ian Fraser and Henry Udow, PDMRs:

 

 

(a) Reed Elsevier Group plc Bonus Investment Plan 2010 ("BIP")

 

Vesting of matching shares

 

In connection with the vesting on 28 February 2014 of the share awards granted in May 2011 under BIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Erik Engstrom, Ian Fraser and Henry Udow after taking account of shares withheld to meet personal tax and national insurance obligations.

 

No. of Reed Elsevier PLC ordinary shares/ADRs* vested

No. of Reed Elsevier NV ordinary shares/ADRs* vested

No. of Reed Elsevier PLC ordinary shares/ADRs* released

No. of Reed Elsevier NV ordinary shares/ADRs* released

Director

Erik Engstrom

55,364*

29,342*

PDMR

Ian Fraser

8,097

39,346

4,291

20,853

Henry Udow

37,758

20,011

9,224*

4,888*

 

*Denotes vesting/release of ADRs. Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares. Each Reed Elsevier PLC ADR represents 4 Reed Elsevier PLC ordinary shares.

 

The closing market price of each security on the date of vesting was £9.155 per Reed Elsevier PLC ordinary share, €15.88 per Reed Elsevier NV ordinary share, $61.48 per Reed Elsevier PLC ADR and $43.67 per Reed Elsevier NV ADR.

 

(b) Reed Elsevier Group plc Long Term Incentive Plan ("LTIP")

 

Vesting of performance shares

 

In connection with the vesting on 28 February 2014 of the share awards granted in May 2011 under LTIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Ian Fraser and Henry Udow after taking account of shares withheld to meet personal tax and national insurance obligations.

 

No. of Reed Elsevier PLC ordinary shares vested

No. of Reed Elsevier NV ordinary shares vested

No. of Reed Elsevier PLC ordinary shares released

No. of Reed Elsevier NV ordinary shares released

PDMR

Ian Fraser

49,214

32,876

26,083

17,424

Henry Udow

47,209

31,536

25,020

16,714

 

The closing market price of each security on the date of vesting was £9.155 per Reed Elsevier PLC ordinary share and €15.88 per Reed Elsevier NV ordinary share.

 

 

 

 

(c) Reed Elsevier Group plc Executive Share Option Scheme ("ESOS"): Exercise of Options

 

The following options to acquire Reed Elsevier ordinary shares were exercised by Erik Engstrom on 4 March 2014.

 

Date of grant

Plan name

No. of Reed Elsevier PLC ordinary shares

No. of Reed Elsevier NV ordinary shares

Option price per share

Director

Erik Engstrom

13 March 2006

ESOS

178,895

£5.305

13 March 2006

ESOS

120,198

€11.470

 

 

(d) Sale of shares

 

On 4 March 2014, Erik Engstrom and Ian Fraser sold the following securities set out below.

 

 

No. of Reed Elsevier PLC ordinary shares/ADRs* sold

Price per Reed Elsevier PLC ordinary shares/ADRs**

No. of Reed Elsevier NV ordinary shares/ADRs* sold

Price per Reed Elsevier NV ordinary shares/ADRs**

Director

Erik Engstrom

174,895

£9.138158

119,198

€15.7552

28,342*

$43.3972**

PDMR

Ian Fraser

26,083

£9.05

38,277

€15.64

 

*Denotes sale of ADRs. Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.

** Denotes price per ADR

 

 

Following these transactions, the current interests of Erik Engstrom in the share capital of Reed Elsevier PLC and Reed Elsevier NV are:

 

Reed Elsevier PLC 118,552 ordinary shares

Reed Elsevier NV 516,765 ordinary shares

 

 

 

- ENDS -

 

 

 

 

Enquiries

 

Paul Abrahams (Media) +44 20 7166 5724

 Colin Tennant (Investors)

+44 20 7166 5751

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSFFULFLSELD

Related Shares:

Relx
FTSE 100 Latest
Value8,275.66
Change0.00